Companies: 10,795·Total market cap: $144.5T
InterCure Ltd.

InterCure Ltd.

INCRNASDAQHealthcare● Active
$0.99
$-0.03(-2.94%)
Market Cap$54134522
P/E Ratio—
52W High$1.77
52W Low$0.68
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

InterCure Ltd. (INCR) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001857030 · INCR · NASDAQ · as of Jun 10, 2026

Filing snapshot

107
Total Filings
6-K
Latest Form
2026-05-01
Most Recent
2019
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001857030 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-04-30
Fiscal Year End
Apr 30, 2026
Accession No.
0001493152-26-020743
Primary Document
form20-f.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001857030 · Accession 0001493152-26-020743

Latest Key Filings

6-KQuarterly Report
6-K
2026-05-01
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
6-K
2026-05-01
View
20-FAnnual Report (Foreign Issuer)
20-F
2026-04-30
View
3Initial Statement of Beneficial Ownership
3
2026-04-20
View
3Initial Statement of Beneficial Ownership
3
2026-04-20
View
3Initial Statement of Beneficial Ownership
3
2026-04-20
View
3Initial Statement of Beneficial Ownership
3
2026-04-16
View
3Initial Statement of Beneficial Ownership
3
2026-04-16
View
3Initial Statement of Beneficial Ownership
3
2026-04-16
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-03-03
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-02-19
View
6-KCurrent Report (Foreign Issuer)
6-K
2025-12-30
View
6-KCurrent Report (Foreign Issuer)
6-K
2025-12-18
View
SCHEDULE 13DSCHEDULE 13D
SCHEDULE 13D
2025-12-09
View
6-KCurrent Report (Foreign Issuer)
6-K
2025-11-25
View
6-KCurrent Report (Foreign Issuer)
6-K
2025-11-03
View
Showing 1–15 of 107 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001857030  |  Exchange: NASDAQ · Healthcare

InterCure Ltd. (NASDAQ: INCR) has submitted 107 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2019. As a Healthcare sector company with CIK 0001857030, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is InterCure Ltd.'s most comprehensive regulatory disclosure. The most recent InterCure Ltd. 10-K was filed on 2026-04-30 for fiscal year ending 2026. Historical INCR 10-K annual reports are available from 2021 through 2026.

Investors researching InterCure Ltd. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-10
Related Companies SEC Filings — Healthcare
EDAP SEC Filings →ASRT SEC Filings →AMWL SEC Filings →UNCY SEC Filings →CRDL SEC Filings →RPTX SEC Filings →FBIO SEC Filings →CAMP SEC Filings →
→ INCR Financials→ INCR Earnings→ INCR Insider Trades

Frequently Asked Questions

INCR SEC Filings · 8 questions

InterCure Ltd. (INCR) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 107 filings and access original documents at no cost. InterCure Ltd.'s CIK is 0001857030.

INCR SEC filingsInterCure Ltd. SEC documentsfind INCR 10-K